Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Fidia Spa ( (IT:FDA) ) has provided an update.
Fidia S.p.A. has issued and placed the third tranche of its convertible bond loan with attached warrants reserved for Global Growth Holding Limited, consisting of 25 bonds with a total nominal value of €250,000. The bonds were subscribed and paid for €187,500 net of fees, and are part of a broader program that has reached a total nominal subscription of €750,000, with €500,000 already subscribed in the related capital increase.
Alongside the bonds, Fidia has issued 2.5 million new warrants to GGHL, each exercisable into one new share at a current price of €0.10 over a 60‑month period, bringing outstanding unexercised POC-related warrants to 7.5 million. The operation strengthens Fidia’s financing structure and provides potential future equity inflows, supporting its investment capacity and positioning in high-performance milling technologies for automotive and aerospace applications.
The most recent analyst rating on (IT:FDA) stock is a Sell with a EUR0.11 price target. To see the full list of analyst forecasts on Fidia Spa stock, see the IT:FDA Stock Forecast page.
More about Fidia Spa
Fidia S.p.A., based in Turin and listed on Euronext Milan, is a global leader in numerical control technology and high-performance integrated milling systems. With over 50 years of experience and about 135 employees, the group supplies numerical controls, high-speed milling machines and CAM software, serving primarily the automotive mold sector and the aerospace industry worldwide.
Average Trading Volume: 1,014,033
Technical Sentiment Signal: Strong Sell
Current Market Cap: €2.03M
Find detailed analytics on FDA stock on TipRanks’ Stock Analysis page.